Related Experiment Video
Updated: Jul 7, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
Let medicine lead the way beyond the registration of clinical trials: registering hypotheses
1Department of Medicine, University of Tennessee, College of Medicine-Chattanooga Unit, Chattanooga, TN 37403, USA. nadesbiens@gmail.com
Abstract:
There has been much recent interest in improving the quality and reporting of clinical research. Major journals now require clinical trialists to register studies a priori and follow specific reporting guidelines. While best developed for randomized, controlled trials, guidelines for other study types are being developed. A hypothesis is presently available for 4 of 5 publications reporting randomized, controlled trials, much less common for other study designs and scarce in the general scientific literature. The declaration of a hypothesis or its absence should be a standard feature of all scientific reporting. The recording of the hypothesis in a registry before data collection would assure readers that the hypothesis was a priori. Medicine has been in the vanguard in requiring methodological rigor in the reporting of science and should again push the envelope by developing a hypothesis registry. If successful, the gauntlet would be thrown down for the rest of science.
Related Concept Videos
Clinical Trials
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Preclinical Development: Overview
Drug Discovery: Overview
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Drug Regulation